Active Sites Display

WP_157729367.1:JDJFOMJM_00804
Sequence length: 1436 aa
4 domain hit(s)
This protein was scanned against CAZyme family profile alignments to identify conserved domains. Each hit below shows a region of the query that aligns to a known CAZyme family. Within each family profile, certain residues are known or predicted to be catalytic — directly involved in the enzyme's chemical reaction. The sequence display compares these critical positions between the query protein and the family consensus:
Match: the query has the expected catalytic residue, suggesting this active site is conserved and likely functional.
Mismatch: the query has a different residue at this position, which may indicate altered activity, a non-functional site, or subfamily variation.
Gap: the catalytic position in the profile has no corresponding residue in the query alignment, suggesting a deletion or truncation in this region.
Match
Mismatch
Gap
Active Site Conservation Analysis
EntryClassNameDomain RangeCoverageConservationCat. SitesMatches
PF16990CBMCarbohydrate binding module (family 35)7–121494.2%43.5%2212
IPR006101GHGlycoside hydrolase, family 22–745100%57.1%22
IPR006215GHGlycoside hydrolase, melibiase1–58787.5%40%82
PF03633GHGlycosyl hydrolase family 65, C-terminal domain1–112489.2%42.9%00
Domain coverage (1–1436 aa)
PF16990 — Carbohydrate binding module (family 35) (domain 7–1214)
Cross-ref: InterPro: IPR005084
GO: GO:0030246 carbohydrate binding
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 1171 1181 1191 1201 1211 1221 1231 1241 1251 1261 1271 1281 1291 1301 1311 1321 1331 1341 1351 1361 1371 1381 1391 1401 1411 1421 1431 Query: MATSPFATYS EADSFRSSVI SKKGSVFSST SWSGDSTYIS AREVTYFNDS SPTIQPIEVG SYTNYYNKTV KSNEEALYPI GTGWSWKMPS VESKDGKKYV HLADGGTYEV SGSTLKGYTW KDLTYAADTS VVVNGVTSAS VLKSENSGIK DYFDSTGRLI KKTDTYGNYV QFLYTTHATY GKVLSRIENS VGNAITITYS PQEVRLTQGD RTVVYTKQAS SAAENKELLT SVTDEAGRRT TYDYAIKAAR FNLLGSTPNT SNPYALVTGV THPTGAKTVY QYEPNVTKRF LGSSAVNETY RLASVSDQLI YSNGTVENKN TKTISYTGDM GSSYSTKMTF AVSILKEGVT TKFDQKKDYI NSSIGAVYYN TKVTQSAGDE QRVVTKTYDE ARRLPVPNQV SNQYIKAGNA AEETTSSQTY DDYGNVLTET DPNGTAKTYV YDSTTHLLKS VSEPISTTQS KKTEYTYNAQ RSPVQVIIKE NDQLLRQKNY DYDSYGNVIT SRDKGTTGDR VQQVEYGAQY QSAFPTKLSV QTIDIDGTPQ NSTQTFEYSL PLGTMTKWAD GRGNITMYEY DKLGRTIKQT SPDLSTQTVT YRDLQNEVEA VDELGLKTIT KFNQLGWKTD VGAVLDGVYQ AKVKYGHDNA GNPIWEEDAL GNRTATKYDP WSRPIELTYA DLTKSTILYN DALRNKSITD SDGATQRETY DKLGRVVLNE SVDAVKGNQV IQKTGYDLVG NMISEEDGNG NRTGYTYNAI GELKRVANAD GQVVTYEYDF LGNLTKILYP DGKFVEKKYD TLGNVIQKTD PLGQIDKYFY DAANNLIKTI NRTGQPKTFG YNNRNFLIQK STQNSTVSYQ YDLTGRRTEM IDGTGDTLYA YSELGFLKSI QLPDGKTLSY AYDSNGNRTK MTDPFGREIF YGINERYHLS TISVGSDSVA PEAEYTFNAA GQVRNTKLQN GTLLERTYDD NKLLVSQIQK NSNSAVVNHF TYQYDAVGNQ TQKIENDSTY TYTYDRQNRI KTSNLFTETY SYDTRGNRES LQTDRPLELS DATYEYDEWD RLVRATTAEG AVVEYVYNGD DQMVERKEGE GITRYYYDGH DIIAEADGTN NNVALKVRYI RGNGLAALET ADGKKAYYTL NGHGDVTELR DENGNLLNQY TYDIWGNVLS KTEQIENSFR YTGEFQDDVT SLIYLRARWY DPSQGRFMNE DTLEGNVNDP LSLNLYTYVS NNPLKYSDPS GHAQADSGYS YSQHPSQKYD YMLNTPAALE IGRLGTLWQI AYKAKDKKSM DSYHAQAEKV RSNACSYLPS GCSIYDINAY FVFDTSGFFV VGATATFTYV AHSTGQIHHL LSNQIMRELK NHITLKGVFD REDPAFKYRA TDADAHKGYQ TWHREYDKRV VRWLQDNPKA TPQSFRNFLH ALHQEPAIRQ RIPGVNLRYK GGQGEQ Profile: ······T·YE ·E······S· ··K·····S· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·······YT· ·········· ·········· ·········· ·········· ········Y· ··RY······ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·····N···· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·····NT··· ·YYS······ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ········D· ·T·N······ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ······
query > profileA7>T1Y9>Y3S10>E4A12>E6gap>N13V19>S14K23>K18S29>S24Y118>Y29T119>T30Y169>Y57L173>R62Y174>Y63D536>N78K886>N112T887>T113Y892>Y118D893>Y119S894>S120D1209>D131S1212>T134N1214>N136
IPR006101 — Glycoside hydrolase, family 2 (domain 2–745)
Cross-ref: InterPro: IPR006101
GO: GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compoundsGO:0005975 carbohydrate metabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 1171 1181 1191 1201 1211 1221 1231 1241 1251 1261 1271 1281 1291 1301 1311 1321 1331 1341 1351 1361 1371 1381 1391 1401 1411 1421 1431 Query: MATSPFATYS EADSFRSSVI SKKGSVFSST SWSGDSTYIS AREVTYFNDS SPTIQPIEVG SYTNYYNKTV KSNEEALYPI GTGWSWKMPS VESKDGKKYV HLADGGTYEV SGSTLKGYTW KDLTYAADTS VVVNGVTSAS VLKSENSGIK DYFDSTGRLI KKTDTYGNYV QFLYTTHATY GKVLSRIENS VGNAITITYS PQEVRLTQGD RTVVYTKQAS SAAENKELLT SVTDEAGRRT TYDYAIKAAR FNLLGSTPNT SNPYALVTGV THPTGAKTVY QYEPNVTKRF LGSSAVNETY RLASVSDQLI YSNGTVENKN TKTISYTGDM GSSYSTKMTF AVSILKEGVT TKFDQKKDYI NSSIGAVYYN TKVTQSAGDE QRVVTKTYDE ARRLPVPNQV SNQYIKAGNA AEETTSSQTY DDYGNVLTET DPNGTAKTYV YDSTTHLLKS VSEPISTTQS KKTEYTYNAQ RSPVQVIIKE NDQLLRQKNY DYDSYGNVIT SRDKGTTGDR VQQVEYGAQY QSAFPTKLSV QTIDIDGTPQ NSTQTFEYSL PLGTMTKWAD GRGNITMYEY DKLGRTIKQT SPDLSTQTVT YRDLQNEVEA VDELGLKTIT KFNQLGWKTD VGAVLDGVYQ AKVKYGHDNA GNPIWEEDAL GNRTATKYDP WSRPIELTYA DLTKSTILYN DALRNKSITD SDGATQRETY DKLGRVVLNE SVDAVKGNQV IQKTGYDLVG NMISEEDGNG NRTGYTYNAI GELKRVANAD GQVVTYEYDF LGNLTKILYP DGKFVEKKYD TLGNVIQKTD PLGQIDKYFY DAANNLIKTI NRTGQPKTFG YNNRNFLIQK STQNSTVSYQ YDLTGRRTEM IDGTGDTLYA YSELGFLKSI QLPDGKTLSY AYDSNGNRTK MTDPFGREIF YGINERYHLS TISVGSDSVA PEAEYTFNAA GQVRNTKLQN GTLLERTYDD NKLLVSQIQK NSNSAVVNHF TYQYDAVGNQ TQKIENDSTY TYTYDRQNRI KTSNLFTETY SYDTRGNRES LQTDRPLELS DATYEYDEWD RLVRATTAEG AVVEYVYNGD DQMVERKEGE GITRYYYDGH DIIAEADGTN NNVALKVRYI RGNGLAALET ADGKKAYYTL NGHGDVTELR DENGNLLNQY TYDIWGNVLS KTEQIENSFR YTGEFQDDVT SLIYLRARWY DPSQGRFMNE DTLEGNVNDP LSLNLYTYVS NNPLKYSDPS GHAQADSGYS YSQHPSQKYD YMLNTPAALE IGRLGTLWQI AYKAKDKKSM DSYHAQAEKV RSNACSYLPS GCSIYDINAY FVFDTSGFFV VGATATFTYV AHSTGQIHHL LSNQIMRELK NHITLKGVFD REDPAFKYRA TDADAHKGYQ TWHREYDKRV VRWLQDNPKA TPQSFRNFLH ALHQEPAIRQ RIPGVNLRYK GGQGEQ Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ········N· ····Y····· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ······
query > profileN739>N10Y745>Y16
IPR006215 — Glycoside hydrolase, melibiase (domain 1–587)
Cross-ref: InterPro: IPR006215
GO: GO:0004557 alpha-galactosidase activityGO:0005975 carbohydrate metabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 1171 1181 1191 1201 1211 1221 1231 1241 1251 1261 1271 1281 1291 1301 1311 1321 1331 1341 1351 1361 1371 1381 1391 1401 1411 1421 1431 Query: MATSPFATYS EADSFRSSVI SKKGSVFSST SWSGDSTYIS AREVTYFNDS SPTIQPIEVG SYTNYYNKTV KSNEEALYPI GTGWSWKMPS VESKDGKKYV HLADGGTYEV SGSTLKGYTW KDLTYAADTS VVVNGVTSAS VLKSENSGIK DYFDSTGRLI KKTDTYGNYV QFLYTTHATY GKVLSRIENS VGNAITITYS PQEVRLTQGD RTVVYTKQAS SAAENKELLT SVTDEAGRRT TYDYAIKAAR FNLLGSTPNT SNPYALVTGV THPTGAKTVY QYEPNVTKRF LGSSAVNETY RLASVSDQLI YSNGTVENKN TKTISYTGDM GSSYSTKMTF AVSILKEGVT TKFDQKKDYI NSSIGAVYYN TKVTQSAGDE QRVVTKTYDE ARRLPVPNQV SNQYIKAGNA AEETTSSQTY DDYGNVLTET DPNGTAKTYV YDSTTHLLKS VSEPISTTQS KKTEYTYNAQ RSPVQVIIKE NDQLLRQKNY DYDSYGNVIT SRDKGTTGDR VQQVEYGAQY QSAFPTKLSV QTIDIDGTPQ NSTQTFEYSL PLGTMTKWAD GRGNITMYEY DKLGRTIKQT SPDLSTQTVT YRDLQNEVEA VDELGLKTIT KFNQLGWKTD VGAVLDGVYQ AKVKYGHDNA GNPIWEEDAL GNRTATKYDP WSRPIELTYA DLTKSTILYN DALRNKSITD SDGATQRETY DKLGRVVLNE SVDAVKGNQV IQKTGYDLVG NMISEEDGNG NRTGYTYNAI GELKRVANAD GQVVTYEYDF LGNLTKILYP DGKFVEKKYD TLGNVIQKTD PLGQIDKYFY DAANNLIKTI NRTGQPKTFG YNNRNFLIQK STQNSTVSYQ YDLTGRRTEM IDGTGDTLYA YSELGFLKSI QLPDGKTLSY AYDSNGNRTK MTDPFGREIF YGINERYHLS TISVGSDSVA PEAEYTFNAA GQVRNTKLQN GTLLERTYDD NKLLVSQIQK NSNSAVVNHF TYQYDAVGNQ TQKIENDSTY TYTYDRQNRI KTSNLFTETY SYDTRGNRES LQTDRPLELS DATYEYDEWD RLVRATTAEG AVVEYVYNGD DQMVERKEGE GITRYYYDGH DIIAEADGTN NNVALKVRYI RGNGLAALET ADGKKAYYTL NGHGDVTELR DENGNLLNQY TYDIWGNVLS KTEQIENSFR YTGEFQDDVT SLIYLRARWY DPSQGRFMNE DTLEGNVNDP LSLNLYTYVS NNPLKYSDPS GHAQADSGYS YSQHPSQKYD YMLNTPAALE IGRLGTLWQI AYKAKDKKSM DSYHAQAEKV RSNACSYLPS GCSIYDINAY FVFDTSGFFV VGATATFTYV AHSTGQIHHL LSNQIMRELK NHITLKGVFD REDPAFKYRA TDADAHKGYQ TWHREYDKRV VRWLQDNPKA TPQSFRNFLH ALHQEPAIRQ RIPGVNLRYK GGQGEQ Profile: YNK····T·· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ····SY···· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ······
query > profilegap>N1gap>C2M1>Y3A2>N4T3>K5T8>T10S585>S14T586>Y15
PF03633 — Glycosyl hydrolase family 65, C-terminal domain (domain 1–1124)
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 1171 1181 1191 1201 1211 1221 1231 1241 1251 1261 1271 1281 1291 1301 1311 1321 1331 1341 1351 1361 1371 1381 1391 1401 1411 1421 1431 Query: MATSPFATYS EADSFRSSVI SKKGSVFSST SWSGDSTYIS AREVTYFNDS SPTIQPIEVG SYTNYYNKTV KSNEEALYPI GTGWSWKMPS VESKDGKKYV HLADGGTYEV SGSTLKGYTW KDLTYAADTS VVVNGVTSAS VLKSENSGIK DYFDSTGRLI KKTDTYGNYV QFLYTTHATY GKVLSRIENS VGNAITITYS PQEVRLTQGD RTVVYTKQAS SAAENKELLT SVTDEAGRRT TYDYAIKAAR FNLLGSTPNT SNPYALVTGV THPTGAKTVY QYEPNVTKRF LGSSAVNETY RLASVSDQLI YSNGTVENKN TKTISYTGDM GSSYSTKMTF AVSILKEGVT TKFDQKKDYI NSSIGAVYYN TKVTQSAGDE QRVVTKTYDE ARRLPVPNQV SNQYIKAGNA AEETTSSQTY DDYGNVLTET DPNGTAKTYV YDSTTHLLKS VSEPISTTQS KKTEYTYNAQ RSPVQVIIKE NDQLLRQKNY DYDSYGNVIT SRDKGTTGDR VQQVEYGAQY QSAFPTKLSV QTIDIDGTPQ NSTQTFEYSL PLGTMTKWAD GRGNITMYEY DKLGRTIKQT SPDLSTQTVT YRDLQNEVEA VDELGLKTIT KFNQLGWKTD VGAVLDGVYQ AKVKYGHDNA GNPIWEEDAL GNRTATKYDP WSRPIELTYA DLTKSTILYN DALRNKSITD SDGATQRETY DKLGRVVLNE SVDAVKGNQV IQKTGYDLVG NMISEEDGNG NRTGYTYNAI GELKRVANAD GQVVTYEYDF LGNLTKILYP DGKFVEKKYD TLGNVIQKTD PLGQIDKYFY DAANNLIKTI NRTGQPKTFG YNNRNFLIQK STQNSTVSYQ YDLTGRRTEM IDGTGDTLYA YSELGFLKSI QLPDGKTLSY AYDSNGNRTK MTDPFGREIF YGINERYHLS TISVGSDSVA PEAEYTFNAA GQVRNTKLQN GTLLERTYDD NKLLVSQIQK NSNSAVVNHF TYQYDAVGNQ TQKIENDSTY TYTYDRQNRI KTSNLFTETY SYDTRGNRES LQTDRPLELS DATYEYDEWD RLVRATTAEG AVVEYVYNGD DQMVERKEGE GITRYYYDGH DIIAEADGTN NNVALKVRYI RGNGLAALET ADGKKAYYTL NGHGDVTELR DENGNLLNQY TYDIWGNVLS KTEQIENSFR YTGEFQDDVT SLIYLRARWY DPSQGRFMNE DTLEGNVNDP LSLNLYTYVS NNPLKYSDPS GHAQADSGYS YSQHPSQKYD YMLNTPAALE IGRLGTLWQI AYKAKDKKSM DSYHAQAEKV RSNACSYLPS GCSIYDINAY FVFDTSGFFV VGATATFTYV AHSTGQIHHL LSNQIMRELK NHITLKGVFD REDPAFKYRA TDADAHKGYQ TWHREYDKRV VRWLQDNPKA TPQSFRNFLH ALHQEPAIRQ RIPGVNLRYK GGQGEQ Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ······
query > profile
↑ Top





v1.01 @copyright 2026 UCLA